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2016 Advances in Renal Imaging Symposium 
IUPUI Campus Center – Lower Level 
Tuesday, November 15, 2016 
Welcome & Overview of Symposium (1:00 - 1:10 PM) 
Bruce A. Molitoris, MD – Division of Nephrology, Department of Medicine, Indiana University School of 
Medicine 
Anantha Shekhar, MD, PhD, Executive Associate Dean for Research Affairs, Indiana University School of 
Medicine; Director - Indiana Clinical and Translational Sciences Institute (CTSI) 
Session 1 (1:10 - 3:10 PM) Session Topic: Need for advances in renal imaging/Potential  targets for 
renal imaging (Chair: Bruce A. Molitoris, MD) 
Talk 1.1 "Role of Renal Imaging in the Kidney Precision Medicine Initiative" (Michael F. 
Flessner MD, PhD – NIDDK, NIH) 
Talk 1.2 "Assessment of Renal Fibrosis Using Magnetization Transfer MRI"  (Lilach O. 
Lerman, MD, PhD – Mayo Clinic) 
Talk 1.3 "The Use of Cationic Ferritin to Quantify Glomeruli In Vivo" (Jennifer R. 
Charlton, MD - University of Virginia) 
Break (3:10 - 3:30) 
Session 2 (3:30 - 5:30 PM) Session Topic: "Advances in in vivo microscopy: extending the reach of 
renal imaging" (Chair: Kenneth W. Dunn, PhD) 
Talk 2.1 “Twice as good? Aspirational and Practical Aspects of Two-Photon Microscopy 
In Vivo” (David W. Piston, PhD - Washington University in St. Louis) 
Talk 2.2 "Label-free Optical Micro Imaging towards in vivo and in situ Assessment of 
Tissue Histology" (Xingde Li, PhD - Johns Hopkins University) 
Talk 2.3 "Intravital Fluorescence Lifetime Imaging Microscopy (FLIM): An Additional 
Dimension for Imaging Physiology" (Richard N. Day, PhD - Indiana University) 
Reception/Poster session (5:30 - 6:30 PM) 
Wednesday, November 16, 2016 
Continental Breakfast (8:00 - 8:30 AM) 
Session 3 (8:30 - 10:30 AM) Session Topic: Advances in molecular, perfusion, structural, … renal 
imaging.  (Co-chairs: Gary D. Hutchins, PhD &  Mark R. Holland, PhD)  
Talk 3.1 "Renal and Urinary Tract Imaging: Classic Approaches and Future Outlook" 
(Brian S. Garra, MD - Washington DC VA Medical Center & FDA DIAM) 
Talk 3.2 "Molecular Magnetic Resonance Imaging of Renal Fibrogenesis" (Peter 
Caravan, PhD – Massachusetts General Hospital and Harvard Medical School) 
Talk 3.3 "Nanotechnologies for Diagnosis and Therapy of Acute Kidney Injury" (Samuel 
A. Wickline, MD - Washington University in St. Louis) 
Title: Role of Renal Imaging in the Kidney Precision Medicine Initiative 
Author: Michael F Flessner, MD, PhD 
Affiliation: KUH, NIDDK, NIH, Bethesda, MD 
Abstract: 
Imaging of molecules, cells, and whole organs have an integral role in advancing 
medical science in the age of "Precision Medicine".  At this time, nephrologists perform 
simple urine and blood tests to diagnose changes in kidney function and then wait, in 
the case of AKI, or start an ACEI or ARB, in the case of CKD.  We know how to control 
diabetes and blood pressure, and we know that APOL1 gene mutations pose a 
significant risk for ESRD, but despite our best efforts, we can merely slow progression 
of the disease.  Nephrologists rarely biopsy patients with diabetes or AKI, and there are 
few validated human targets to push drug development.  In contrast, oncology has 
coupled multi-omics data with histology to tease out subgroups, pathways, and targets.  
This approach offers the opportunity to change Nephrology's culture and advance the 
study of kidney with not only phenotypic data but new histological approaches coupled 
with a human cell atlas and cell specific omics. 
The Kidney Precision Medicine Project (KPMP) has three major components: 
recruitment sites, tissue interrogation sites, and a central hub to coordinate data and 
sample collection, digital pathology and collaboration.  Recruitment sites will explore 
ways to safely obtain kidney tissue, and in vivo imaging will be correlated with the 
histopathology, the phenotype,  and the genomic study of the tissue.  Several speakers 
in this conference will address the different methods of study from elastography to MRI.  
Newly developed MRI tracers offer the promise of measuring the number of glomeruli or 
the degree of fibrosis and monitoring the response to potential therapies.  The Tissue 
Interrogation Sites will receive the tissue from the Recruitment Sites and will use state 
of the art techniques and develop/optimize the "next generation" tissue interrogation 
methods.  Some examples of these techniques will be discussed in this conference: 
single cell analysis using multi-color fluorescence fluctuation spectroscopy, optical 
coherence tomography, and use of Forster Resonance Energy Transfer Biosensors.  All 
of these techniques have potential application in the KPMP tissue interrogation.  This is 
an exciting time for nephrology and biomedical science. 
“Advances in Renal Imaging” symposium: 
Assessment of renal fibrosis using magnetization transfer MRI 
Kai Jiang, Christopher C. Ferguson, Slobodan I. Macura, Lilach O. Lerman. Mayo Clinic, Rochester, MN. 
Renal artery stenosis (RAS) decreases renal blood flow and causes a progressive loss of renal function. 
The stenotic kidney undergoes progressive deposition of extracellular matrix that evolves into tubulointerstitial 
fibrosis, an important prognostic factor in renal disease. Currently, renal biopsy is the reference method to 
assess renal fibrosis, but is limited by invasiveness, possible sampling error, and intra/inter-observer variability.  
Several magnetic resonance imaging (MRI) techniques have been explored for noninvasive detection of 
renal fibrosis. Diffusion-weighted imaging is sensitive to changes in microstructure and is capable of detecting 
renal fibrosis, but is non-specific and largely affected by structural and functional alterations besides fibrosis. 
MR-elastography (MRE) measures the stiffness of tissues, which may be elevated due to fibrosis among other 
causes. MRE-determined medullary stiffness correlated well with medullary fibrosis in swine RAS kidneys, 
whereas cortical stiffness was also dependent on perfusion pressure. Alternatively, magnetization transfer 
imaging (MTI) can be used to evaluate the presence of macromolecules, e.g., proteins, lipids, carbohydrates 
and nucleic acids in tissues. MTI was applied empirically for the evaluation of nephropathy, including unilateral 
ureteral obstruction and polycystic kidney disease.  
In a recent study, we evaluated the ability of MTI to assess the progression of renal fibrosis in mice with 
unilateral RAS. The stenotic and contralateral kidneys were studied longitudinally in-vivo at baseline and 2, 4 
and 6 weeks after RAS (n=10) or sham surgery (n=5). After a 16.4T MRI exam, magnetization transfer ratio 
(MTR) was measured as an index of fibrosis. Renal volume, perfusion, blood flow and oxygenation were also 
assessed with micro-MRI. Fibrosis was subsequently measured ex-vivo by histology and hydroxyproline assay. 
In the stenotic kidney, we found that the median MTR showed progressive increases from baseline to 6 
weeks in the cortex by (+13.7%) and medulla (+21.3%), which were accompanied by a progressive loss in 
renal volume, perfusion, blood flow, and oxygenation. The 6-week MTR map showed good correlation with 
fibrosis measured ex-vivo with trichrome staining, Sirius red staining, and the hydroxyproline assay). 
Therefore, MTI successfully measured and longitudinally monitored the progression of renal fibrosis in mice 
with unilateral RAS. Future studies are needed to determine its sensitivity and applicability in 3T MRI. 
Figure: Renal fibrosis in 
mice by in-vivo MTI and ex-
vivo histology or 
hydroxyproline assay. (a) 
MRI image without MT 
pulses (left), MT-weighted 
image with the manually 
traced ROIs in the cortex 
and medulla (middle) and 
calculated MTR maps 
overlapped with the baseline 
image (right). (b) Trichrome 
staining (left), Sirius red 
staining under polarized light 
(middle) (x 10), and 
corresponding MTR map 
(right) of a stenotic kidney at 
6 weeks of RAS. Areas 
representing fibrosis, 
necrosis, and pelvis are 
marked by red, black, and 
white arrows, respectively. 
(c) Spearman’s rank 
correlation of fibrosis 
quantified from ex-vivo 
trichrome staining (left), 
Sirius red staining (middle) 
or hydroxyproline assay 
(right) and in-vivo MTR. 
Stenotic Kidney
The use of cationic ferritin to quantify glomeruli in vivo 
 
Jennifer R Charlton1, Edwin J Baldelomar2, Teresa Wu3, Kevin M Bennett4 
 
1University of Virginia, Charlottesville, VA1; University of Hawai’i, Manoa, Department of Physics and 
Astronomy2 and Biology4; Arizona State University Tempe, AZ 
 
The progression of chronic kidney disease 
(CKD) is insidious and often silent. Abnormal 
clinical diagnostic testing may indicate a state 
of nephron deficiency with permanent and 
extensive renal damage. The most clinically 
relevant biomarker for renal disease 
progression, glomerular filtration rate (GFR), 
has poor sensitivity and lacks predictive value 
due to the kidney’s significant adaptive 
mechanisms that mask a reduced 
complement of functioning nephrons. The late 
manifestations of CKD and absence of early 
diagnostic tools to detect patients at risk of 
developing CKD have contributed to the 
inability to effectively halt the progression of 
this disease. The long-term goal of our team 
is to identify patients at risk for CKD to slow or 
halt the progression of this deadly and morbid 
condition. To accomplish our long-term goal, it 
is critical to develop the tools to acquire 
nephron number in a safe, noninvasive, and 
repeatable manner, translatable to patient 
care.    
We have developed the technique of cationic 
ferritin enhanced-MRI (CFE-MRI) to detect 
and measure the size of individual perfused 
glomeruli of mice in 3D MRI1 . CF binds to the 
GBM after intravenous injection and is visible 
in MRI as hypointense spots in labeled 
glomeruli of the cortex (Figure 1a)2,3 . Without 
CF, glomeruli are not visible by MRI, 
regardless of the magnet field strength. While 
the number (Nglom) and volume (Vglom) 
measured by CFE-MRI are comparable to 
average values obtained using stereologic 
techniques, additional information gained 
from CFE-MRI includes intra-renal distribution 
of Vglom, integration of kidney compartments 
with 3D spatial resolution and a measure of 
GBM integrity and glomerular functionality. 
CFE-MRI has been extensively validated in 
healthy animals and human kidneys 
unsuitable for organ donation1,3-5 . We 
showed that CFE-MRI can detect glomerular 
pathology in human kidneys prior to a change in renal function. These changes would not have been captured 
in histologic assessments from a biopsy (Figure 1). Our laboratories have continued to pushexpanded our 
ability to detect and measure glomeruli using CFE-MRI and now can identify of ALL perfused glomeruli in the 
kidney providing a unique view of total nephron endowment (Figure 2) and renal microstructure, both in vivo 
and ex vivo.  Further work is required to determine how glomerular microstructure changes in disease and 
during disease progression.  Imaging individual nephrons of the entire kidney provides a new avenue to 
explore the complex temporal and spatial relationships during the development of CKD.  
Figure 1.  CFE-MRI is used to measure glomerular morphology 
in human kidney ex vivo 4 . (A) MR image of the kidney 
demonstrating large patchy regions of cortex lacking CF-labeled 
glomeruli.  (B) The regions of cortex with CF-labeling showed mild 
sclerosis on histologic examination, but (C) the cortical areas that 
lacked CF reveal severe sclerosis of glomeruli and arterioles.  The 
significant proportion of renal damage may be unappreciated by 
histologic assessments and the CFE-MRI changes precede renal 
functional changes.     
Figure 2: CFE MRI detects glomerular morphology in vivo in 
rats: a) 3D reconstruction of the MRI dataset showing CF-labeled 
glomeruli in the rat kidney in vivo. B) Glomeruli are segmented in 3D 
and c) Glomeruli are measured and counted in the images. Colored 
dots are individual, CF-labeled glomeruli in 2d slices from the 3D MRI 
dataset. The in vivo and ex vivo measurements of Nglom and Vglom are 
not different.
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Twice as good? Aspirational and Practical Aspects of Two-Photon Microscopy in Vivo 
David W. Piston, Ph.D. 
Department of Cell Biology & Physiology 
Washington University School of Medicine 
 Two-photon excitation microscopy provides attractive features, especially for optical 
sectioning deep into intact tissues or whole animals.  The advantages of two-photon microscopy 
over linear optical sectioning techniques, such as confocal microscopy, are greater imaging 
depths and reduced overall photo-toxicity.  Since two-photon microscopy enables dynamic 
cellular measurements, the extra depth penetration opens up a broad range of experiments that 
rely on non-invasive intra-vital imaging of cellular and sub-cellular processes.  While two-
photon microscopy provides the capability to perform quantitative imaging in tissues at depths 
well beyond those that can be reached with confocal microscopy, inherent difficulties with the 
non-linear optics underlying two-photon microscopy limit its main usefulness to deep-tissue 
imaging and a few other specialized applications.  These photophysical limitations can also 
affect the interpretation of in vivo data, especially in situations where tissue autofluorescence is 
significant.  
 Imaging of anything thicker than a monolayer cell culture is limited by out of focus 
background, which can be overcome by using an optical sectioning approach, such as confocal 
microscopy.  However, imaging live samples with confocal microscopy can create deleterious 
effects in the sample, in particular due to photobleaching of the probes and the phototoxicity of 
the excitation light.  The physics underlying two-photon microscopy allows much deeper 
imaging with two-photon microscopy since it is much less susceptible to degradation by out-of-
focus absorption and scattering.  A good rule of thumb is that two-photon microscopy can 
provide useful image data about 6 times deeper into tissue than can confocal microscopy.   
 While two-photon microscopy was initially demonstrated over 25 years ago [1], for the first 
~15 years, its use was limited to specialist laboratories due to the expertise needed to control the 
sophisticated ultra-fast laser technology required for two-photon microscopy.  Nowadays, 
reliable ‘turn-key’ laser systems have been developed, allowing a hands-off approach to two-
photon microscopy and rendering it as easy to drive as commercial confocal microscopes.  This 
has allowed two-photon microscopy to transition from a novelty of the laser laboratory into a 
useful tool in a true biological research setting, where investigators can concentrate on studying 
the biological question at hand without worrying about aligning, operating, and maintaining the 
microscope system.  Beyond the instrumentation advances, though, greater understanding of 
two-photon microscopy and its advantages has allowed this technique to be effectively utilized in 
biological research.   
 This talk will cover the basics of two-photon microscopy and how the underlying 
photophysics leads to both its advantages and limitations.  To take full advantage of its strengths, 
the instrumentation design needs to be optimized for two-photon microscopy, and the practical 
aspects of two-photon photophysics and image formation need to be understood.  Once these 
hurdles are overcome, the results can be stunning.  Some recent examples of two-photon 
microscopy will be presented to highlight the wide range of physiological studies not only in the 
imaging of the kidney, but also in neuroscience, developmental biology, immunology, cancer 
and endocrinology. 
Label-free Optical Micro Imaging towards in vivo and in situ  
Assessment of Tissue Histology 
Wenxuan Liang, Scott W. Yuan, Jessica Mavadia-Shukla, Ang Li, and Xingde Li 
Department of Biomedical Engineering, Johns Hopkins University School of Medicine, 
Baltimore, MD 21205 USA 
Recent years have witnessed rapid development of high-resolution optical imaging technologies 
such as optical coherence tomography (OCT) and multiphoton microscopy. These technologies 
have shown significant potential to be translated to clinical practice for imaging tissue 
microanatomies in vivo at a resolution approaching or at standard histopathology but without the 
need for tissue removal or processing. Thus they can function as a form of noninvasive “optical 
histology”, which can potentially address various unmet clinical needs in early disease detection, 
guidance of surgical intervention, and assessment of treatment outcome. By taking advantages of 
some intrinsic fluorophores such as NADH and FAD, in vivo functional histology of biological 
tissues becomes possible. This presentation will briefly go over the evolution of these 
technologies and then focus on our recent advances in ultracompact endomicroscopy 
technologies, which literally miniaturize a bench-top scanning laser microscope down to a 
flexible fiber-optic scanning probe of an ~1-2 mm diameter. As one of the most recent 
technological developments, such a technology enables us to put a “microscope” inside an 
animal or human body. The physics principles, engineering challenges, (big) data and image 
processing challenges, and potential solutions will be briefly discussed, including the 
development of advanced lasers, MEMS technology, special optical fiber, ultracompact and 
high-performance micro optics, speckle noise reduction, image segmentation and optical staining 
techniques. Representative applications of these high-resolution technologies will be presented, 
including cancer detection, airway physiology assessment, and intra-operative guidance for 
neurosurgery. Potential applications for functional assessment of kidney microtubules in vivo and 
in a label-free fashion will also be presented. Other potential applications of these biophotonics 
imaging tools for basic research will also be discussed.  
Intravital fluorescence lifetime imaging microscopy (FLIM): an additional 
dimension for imaging physiology 
Takashi Hato1, Seth Winfree1, Ruben Sandoval1, Bruce Molitoris1, Kenneth Dunn1, Pierre Dagher1 and 
Richard Day2 
1Departments of Medicine and 2Cellular and Integrative Physiology, Indiana University School of Medicine, 
Indianapolis, Indiana. 
The use of two-photon laser-scanning microscopy (TPLSM) to monitor probe or auto-fluorescence signals 
from the tissues of living animals is of particular interest to many laboratories because it allows real-time 
detection of specific cellular events in their natural environment.  The fluorescence signals acquired during 
imaging are typically separated into distinct spectral channels for analysis.  There is, however, another 
dimension that can be captured by TPLSM – the fluorescence lifetime of the emission signals – that is often 
ignored in the analysis.  Fluorescence lifetime is the average time that a molecule spends in the excited state 
before returning to the ground state through the emission of a photon.  The fluorescence lifetime is an intrinsic 
property of a fluorophore and carries information about events that affect the excited-state.  The lifetime 
information captured by TPLSM is visualized using phasor plots, which are a simple geometric representation 
of the frequency characteristics of the emission signal from each image pixel.  The phasor transformation 
allows the rapid determination of the lifetimes of fluorescence signals emanating from tissues, and does not 
require any a priori knowledge of the fluorescent species.  In the live animal, tissue auto-fluorescence arises 
principally from several biologically important metabolites, including the flavoproteins (FAD) and the reduced 
form of nicotinamide adenine dinucleotide (NADH).  The phasor analysis of these auto-fluorescence signals 
can be used to generate “fingerprints” that identify the unique metabolic states of different cell-types within a 
tissue, providing a label-free imaging tool to study metabolism in vivo.  Here, we will describe how the 
combination of intravital TPLSM and frequency domain FLIM is used to map cell-specific metabolic signatures 
in the kidney of live animals. The phasor analysis of the FLIM images enables a bias-free approach to 
characterize and monitor metabolism in vivo and offers the unique opportunity to uncover dynamic metabolic 
changes in living animals with subcellular resolution.  
Renal and Urinary Tract Imaging: Classic Approaches and Future Outlook 
Brian S Garra, M.D. 
Washington DC VA Medical Center 
and  
Division of Imaging, Diagnostics and Software Reliability, CDRH, FDA 
Renal and Urinary Collecting System Imaging, once focused on the challenge of renal mass diagnosis, has evolved 
into more of a detection and patient management tool.   With the advent of mildly  invasive  treatments of renal 
cancer, the need to reliably make a preoperative diagnosis has diminished since treatment often no longer involves 
a major operation.  Even as the need for “perfect” diagnostic tools has decreased, diagnostic capabilities of existing 
tools have increased. 
Diagnostic modalities used for renal evaluation include: plain radiography and radiographic urography, sonography 
(US),  computed  tomography  (CT),  magnetic  resonance  imaging  (MRI),  Radionuclide  Scanning  (NM),  Renal 
Arteriography, and retrograde pyelography.  Plain radiography is insensitive for most types of renal pathology and 
is  currently  used  only  to  follow  renal  and  ureteral  calculi  if  they  are  visible  on  the  examination.  Radiographic 
urography,  also  known  as  excretory  urography  and  intravenous  pyelography  (IVP),  involves  taking  multiple 
radiographs at several times  following  injection of water soluble contrast material  intravenously.    It  is useful  for 
evaluation of the overall anatomy of the kidneys and collecting systems and especially for delineating the extent 
and severity of a collecting system obstruction.  Because of its limited ability to delineate and detect small solid or 
cystic masses of the kidneys or bladder, the method has been largely replaced by CT Urography in which CT takes 
the  place  of  radiography  for  imaging  the  kidneys  and  collecting  systems.  Ultrasonography  detects  and 
characterizes renal and bladder masses well and  is useful for measurement of renal size and cortical thickness  in 
chronic renal disease.  It is especially useful for detection of obstruction of the urinary tract and can reliably detect 
stenosis of the renal arteries.  Image quality degrades considerably in larger patients.   
CT provides similar information to that of ultrasound but is less operator dependent and is not degraded by patient 
size.    Because  it  is  typically  performed  using  intravenous  contrast,  it  can  also  provide  information  on  kidney 
function and can characterize the vascularity of renal masses. It  is the most sensitive method for detection renal 
stones.   MRI provides anatomic  information  similar  to  that of US and CT but provides more  information about 
possible masses  than  CT when  IV  contrast  cannot  be  used.    It  is  sensitive  to motion  artifacts  due  to  patient 
movement and bowel movement  so often produces  less useful  images  that CT.    It  cannot  reliably detect  renal 
calcifications or  calculi. Radionuclide  scanning  is primarily useful  for evaluation of  renal  function and degree of 
renal perfusion.  It is by far the most reliable method for early detection of backflow (vesico‐ureteral reflux) from 
the bladder  into  the ureters and  kidney. Renal arteriography  is  the gold  standard  for detection and grading of 
narrowing  of  the  renal  arteries  and  also may  be  useful  for  characterization  of  renal mass  vascularity  –  vessel 
morphology.  Retrograde pyelography provides the most detailed evaluation of the urinary collecting system and 
can be used when renal function is poor.   
US  and  CT  have  become  the  primary  imaging  modalities  because  in  combination  they  reliably  detect  and 
characterize most anatomic abnormalities and  can be used  to guide biopsies and direct  various  treatments  for 
obstruction  and  for masses. With  the  advent  of  contrast  enhanced  ultrasound  (CEUS), US may  supplant  CT  in 
thinner  patients,  in  patients  with  poor  kidney  function  or  with  contrast  allergy  for  mass  detection,  mass 
characterization and perhaps in evaluation of renal perfusion.  Volumetric quantification of kidney size using both 
CT and US will further  improve monitoring of progression of chronic renal disease.    Improvements  in volumetric 
perfusion  estimation  using  CT,  US  Doppler,  and  CEUS  may  allow  CT  and  US  to  supplant  NM  for  renal 
perfusion/function evaluation.  New forms of quantitative US backscatter may also detect microscopic changes in 
kidney structure that can be used to monitor diffuse renal disease and early diabetic nephropathy. Finally, CEUS 
and CT using  iterative reconstruction may allow more complete renal evaluation without the risks of  IV contrast 
injection.    Taken  together,  these  advances  will  result  in  gradual  but  important  improvements  in  imaging  for 
diagnosis and monitoring of all forms of renal disease. 
Molecular magnetic resonance imaging of renal fibrogenesis 
Philip Waghorn1, Iris Chen1, Nicholas Rotile1, Lan Wei2, Robert Colvin3, Bryan Fuchs2, 
Peter Caravan1. 
1.MGH/HTS A. A. Martinos Center for Biomedical Imaging, Massachusetts General
Hospital and Harvard Medical School. 
2.Division of Surgery, Massachusetts General Hospital.
3 Department of Pathology, Massachusetts General Hospital. 
Objective: 
Current noninvasive methods to detect and stage renal fibrosis are limited and there are 
no methods to distinguish active disease (fibrogenesis) from stable scar.  The objective 
of this work was to develop a molecular magnetic resonance (MR) imaging probe to 
image fibrogenesis. During active fibrogenesis, lysyl oxidase (LOX) enzymes catalyze 
the oxidation of collagen lysine residues to form allysine, which enable collagen 
crosslinking. Quantification of allysine content would thus provide a means to determine 
the extent of disease activity. We report the use of ‘GdOA’ a novel gadolinium based MR 
probe designed to target allysine for non-invasive imaging of renal fibrogenesis.  
Methods: 
GdOA was synthesized and its interaction with allysine characterized.  Two cohorts of 
mice were studied: Group A) sham-treated, and Group B) a nephrotoxic nephritis (NTN) 
model. For the NTN group ‘129’ mice were dosed at day 0 with 250 μg Sheep IgG and 
then with 125 μL sheep anti-rat GBM serum at day 5. Baseline MR kidney images were 
acquired at day 17. Animals were then injected with GdOA and imaged again at 24h 
post GdOA injection. Animals were co-injected with EuDOTA as a non-binding control 
probe. Following MR imaging, kidneys were harvested and assessed for hydroxyproline 
content, Gd content in tissue and for histology. 
Results: 
The NTN model resulted in diffuse tubular injury (30-60%) with intratubular casts and 
fibrosis as indicated by trichrome staining and collagen III immunostaining. Renal 
hydroxyproline content was 65% higher in NTN animals compared to sham animals 
(p<0.001) Administration of GdOA resulted in a 5.7 fold increase in the change in 
relaxation rate, ∆R1, in the NTN group compared to sham mice (p<0.047), correlating 
with increased GdOA uptake in fibrotic kidney. Ex vivo quantification of Gd revealed a 
6.5 fold increase in Gd content in the NTN mice compared to sham mice (p<0.001). 
GdOA kidney uptake in NTN mice was much higher than the non-targeted control 
EuDOTA but there was little difference between the compounds in the sham group.  ∆R1 
showed strong correlations with hydroxyproline (r = 0.92) and Gd content in tissue (r = 
0.84). 
Conclusion: 
Imaging renal fibrosis with GdOA has shown strong correlation between MR signal and 
the extent of disease as measured by tissue content of collagen and total Gd content in 
tissue. GdOA may be a useful molecular probe for staging renal fibrosis and 
fibrogenesis. 
Principal Investigator/Program Director (Last, First, Middle): Chen, Junjie
Nanotechnologies for Diagnosis and Therapy of Acute Kidney Injury 
Samuel A. Wickline, M.D., Junjie Chen, D.Sc. 
Washington University School of Medicine, St Louis, MO. 
Rationale: Interest is keen for the pursuit of methods for quantifying structural and functional disruption 
in progressive chronic kidney disease and acute injury that might improve the sensitivity, specificity, and time in 
which renal injury is diagnosed, and facilitate risk stratification and/or provide prognostic information including 
prediction of recovery of renal function.  Furthermore, novel therapeutic strategies are needed to meet the 
medical need for both safe and effective preventative and post-injury applications in AKI.  
Imaging: Multinuclear 1H/19F MRI coupled 
with perfluorocarbon nanoparticle (PFC NP) contrast 
agents provides a noninvasive quantitative readout of 
kidney hypoperfusion and tissue injury (Figure 1).  
PFC NP are a class of clinically approved vehicles with 
no apparent toxic effect on the kidney.  As a blood-
pool agent, the linear relationship between the 19F 
signal intensity and PFC NP concentration enables a 
direct measurement of blood volume in tissues.  In 
addition, the relationship between the 19F relaxation 
time (R1 = 1/T1 ) of PFC NP and dissolved O2, which 
alters 19F relaxation linearly according to pO2, can be 
utilized for in vivo assessment of pO2  in blood and 
tissue. Finally, functionalized PFC NP carrying 
selected targeting ligands that can bind to and report 
inflammatory markers (e.g. VCAM-1) may allow early 
detection of inflammatory kidney diseases. 
 Therapy:  We have developed and tested 
antithrombin nanoparticles for inhibition of 
microvascular thrombosis in ischemia-reperfusion 
injury (IRI). We designed PPACK (phenylalanine-
proline-arginine-chloromethyl-ketone) loaded PFC NP 
function as an in vivo anti-thrombin agent that 
effectively inhibits arterial thrombosis and platelet 
deposition in mice. In AKI, PPACK PFC NP 
effectively inhibit microvascular coagulation in mice 
(Figure 2). Mice were pre-treated (30 min) with 
1ml/kg PPACK NPs or plain NP before unilateral 
IRI. At 3 hours after reperfusion, 19F MRI registered 
higher concentrations of trapped NP in IRI kidneys 
than that in contralateral uninjured kidneys of the 
same mice, suggesting a reduction of intrarenal 
coagulation. To our knowledge, this is the first 
investigation of nanoparticle-facilitated anti-
thrombotic therapy for AKI, where the effect is 
directly quantifiable by imaging. 
Figure 2 Acute Kidney Injury Model: PPACK PFC NPs Inhibit 
Coagulation and Microangiopathy in AKI.  Left:  Ex vivo 19F MRI 
of kidney coregistered with 1H anatomic image. Right: Ex vivo 19F 
quantification of trapped PFC NP due to coagulation 
Figure 1 MRI methods for quantifying ischemic kidney 
injury. In vivo hyperoxic 1H T2*-weighted image, 19F spin 
density weighted (blood volume) image (11.7T) and pO2 map 
in the left control (a-c) and right injured (d-f) kidneys in one 
mouse at 24 hr post 60 min unilateral warm ischemia. The 
insert in f shows 19F MRI detected pO2 map of another mouse 
kidney during acute ischemia: note marked global hypoxia (all 
blue). White arrow (e): injured CM junction; white cross: PFC 
2016 Advances in Renal Imaging Symposium 
 POSTER SESSION 
Tuesday, November 15, 2016; 5:30 – 6:30 PM 
 
Poster Title 
1 “Indiana Consortium for Innovation in Biomedical Imaging”. Gary D. Hutchins and Mark R. Holland; Indiana 
University-Purdue University Indianapolis & Indiana University School of Medicine 
2 “Research Center for Quantitative Renal Imaging”. Bruce A. Molitoris, Gary D. Hutchins, and Mark R. Holland, 
Indiana University-Purdue University Indianapolis & Indiana University School of Medicine 
3 “Indiana Center for Biological Microscopy”. Kenneth Dunn, Malgorzata Kamocka, Seth Winfree, Bruce 
Molitoris; Indiana University School of Medicine 
4 “The 3D Bioprinting Core at IUSM/IUPUI”. Lester J. Smith, & Nicanor  I. Moldovan;  Indiana University-Purdue 
University Indianapolis & Indiana University School of Medicine 
5 “Image-based Computational Assessment for Severity of Renal Artery Stenosis”. Huidan (Whitney) Yu1,2, 
Anurag Deb1, Avinash Mumbaraddi1, Alan P. Sawchuk2, Raghunandan Motaganahalli2, Michael C. Dalsing2; 
1Indiana University-Purdue University, Indianapolis; 2Indiana University School of Medicine 
6 “The Complex Hemodynamics in Aortorenal Vessel System”. Alan P. Sawchuk2, Huidan (Whitney) Yu1,2, 
Michael C. Dalsing2; 1Indiana University-Purdue University, Indianapolis; 2Indiana University School of 
Medicine 
7 “High Frequency Ultrasound of In Vivo Murine Renal Artery and Vein Blood Flow.” Frederick Damen1, Arvin 
Soepriatna1, Shelby Abrams1, Amy Bogucki1, Ron Korstanje2, Craig J. Goergen1; 1Purdue University; 2The 
Jackson Laboratory, Bar Harbor, ME 
8 “Detection of Lipid-Laden Plaques by Intravascular Ultrasound and Photoacoustic Dual-Modality Imaging”. 
Ayeeshik Kole1,2, Yingchun Cao2, Jie Hui2, Pu Wang2, Islam Bolad1, Ji-Xin Cheng1,2, Michael Sturek1,2;  1 
Indiana University School of Medicine, 2 Purdue University 
9 “Combination of micro CT with infrared spectroscopy provides the most complete approach for stone 
analysis”. James C. Williams, Jr. and James E. Lingeman; Indiana University School of Medicine 
10 “Magnetization Transfer MRI Noninvasively Detects Renal Fibrosis Swine Atherosclerotic Renal Artery 
Stenosis at 3.0 T”. Kai Jiang, Christopher M. Ferguson, John R. Woollard, James D. Krier, and Lilach O. 
Lerman; Mayo Clinic, Rochester, MN 
11 “Magnetic Resonance Diffusion Tensor and q-space imaging in an Animal Model of Chronic Kidney Disease”. 
Sourajit M. Mustafi,Paul R. Territo, Brian P. McCarthy, Amanda A. Riley, Jiang Lei, Chen Lin, Qiuting Wen, 
Bruce A. Molitoris, Gary D. Hutchins, and Yu-Chien Wu:  Indiana University School of Medicine 
12 “Development of a Novel Magnetic Resonance Imaging (MRI) Acquisition and Analysis Workflow for the 
Quantification of Renal Hemorrhagic Injury”. Paul R. Territo, Rajash K. Handa, Philip M. Blomgren, Lin Chen, 
Cynthia D. Johnson, Lie Jiang, Bret A. Connors and Gary D. Hutchins; Indiana University School of Medicine 
13 “Volumetric Comparison of Automatically Segmented Hippocampal Subfields from 4-Min Accelerated versus 
8-Min T2-weighted 3T MRI Scans”. Shan Cong, Shannon L. Risacher, John D. West, Yu‐Chien Wu, Liana 
Apostolova, Eileen Tallman, Maher Rizkalla, Paul Salama, Andrew J. Saykin, Li Shen; Indiana University 
Purdue University Indianapolis & Indiana University School of Medicine 
14 “Physics of Drug Transport”. Meysam Tavakoli1, Konstantinos Tsekouras1, Richard Day2, Ken Dunn2, and 
Steve Pressé1; 1Indiana University-Purdue University, Indianapolis; 2Indiana University School of Medicine. 
15 “The Growth and Impact of ADNI Genetics Publications as Measured by Science Mapping”. Xiaohui Yao1,2, 
Jingwen Yan1,2, Michael Ginda3, Katy Borner3, Sungeun Kim1,8, Kwangsik Nho1, Shannon L. Risacher1, 
Tatiana M. Foroud1, Steven G. Potkin4, Paul M. Thompson5, Jason H. Moore6, Michael W. Weiner7, Andrew J. 
Saykin1, Li Shen1,2, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI); 1IU School of Medicine; 2IU 
School of Informatics and Computing; 3IU School of Informatics and Computing, Bloomington, IN; 4University 
of California, Irvine, CA; 5USC Keck School of Medicine, Los Angeles, CA; 6School of Medicine, University of 
Pennsylvania, Philadelphia, PA; 7UCSF School of Medicine, San Francisco, CA, USA; 8Department of 
Electrical and Computer Engineering, Oswego, NY 
 
Indiana Consortium for Innovation in Biomedical Imaging 
Gary D. Hutchins and Mark R. Holland 
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The Indiana Consortium for Innovation in Biomedical Imaging (Indiana-CIBI) has been established to 
leverage the biomedical imaging strengths of several major academic institutions throughout Indiana. This 
initiative provides the environment, infrastructure, and resources necessary for establishing one of the premier 
translational, research and educational imaging networks in the United States. The Indiana-CIBI will facilitate 
the identification of crucial clinical problems and unmet research needs; stimulate the development of 
innovative solutions; and help translate optimized patient care services into practice at partner health-care 
delivery facilities. 
The objectives of the Indiana-CIBI include: 
 Providing national leadership in translation from concept to practice.  
 Encouraging targeted problem-driven technology development.  
 Nurturing innovation and progress through facile access to advanced resources.  
 Focusing Indiana state-wide interdisciplinary partnerships in the development of new, innovative 
imaging technologies and the utilization of imaging resources. 
 Cultivating investigator engagement and channeling intrinsic motivation. 
The stated objectives of the Indiana-CIBI define the operational model for the consortium. Key steps in the 
innovation-focused process include: 1) Identification of critical clinical or biomedical research needs by 
physician or biomedical investigator(s); 2) Creation of innovative solutions through innovation incubator teams, 
imaging innovation marathons, and crowdsourcing solicitations; 3) Translation to practice through a large 
medical physics/radiology network; and 4) Translation to advanced core services through the Indiana-CTSI 
core resource network. Critical success factors for the Indiana-CIBI include tight integration within academic 
health care facilities, consolidation of fragmented resources, and expansion of critical support resources, 
eliminating the need to duplicate some types of services across multiple sites in Indiana. 
For further information regarding the Indiana Consortium for Innovation in Biomedical Imaging and its 
programs please contact Mark Holland or Gary Hutchins at incibi@iupui.edu. The Indiana-CIBI is supported, in 
part, by contributions from the IUPUI Office of the Vice Chancellor for Research. 
 
 Research Center for Quantitative Renal Imaging 
Bruce A. Molitoris, Gary D. Hutchins, and Mark R. Holland 
 
Indiana University-Purdue University Indianapolis & Indiana University School of Medicine 
Mission: The overall mission of the Research Center for Quantitative Renal Imaging is to provide a focused 
research environment and resource for the development, implementation, and dissemination of innovative, 
quantitative imaging methods designed to assess the status of and mechanisms associated with acute and 
chronic kidney disease and evaluate efficacy of therapeutic interventions. 
Nature of the Center: IUPUI has several established research programs focused on understanding the 
fundamental mechanisms associated with kidney diseases along with established groups of investigators 
dedicated to the development of advanced imaging methods and quantitative analyses.  This Research Center 
provides a formal mechanism to link these independently successful research efforts into a focused effort 
dedicated toward the development and implementation of quantitative renal imaging methods.   
The goals of the IUPUI Research Center for Quantitative Renal Imaging are to: 
 Identify, develop, and implement innovative imaging methods that provide quantitative imaging 
biomarkers for assessing and inter-relating renal structure, function, hemodynamics and underlying 
tissue micro-environmental factors contributing to kidney disease. 
 Establish an environment that facilitates and encourages interdisciplinary collaborations among 
investigators and offers research support to investigators focused on developing and utilizing innovative 
quantitative imaging methods in support of kidney disease research. 
 Provide a resource to inform the greater research and healthcare communities of advances in 
quantitative renal imaging and its potential for enhanced patient management and care. 
 Offer an imaging research resource to companies engaged in product development associated with the 
diagnosis and treatment of kidney diseases. 
Further Information: For further information regarding the IUPUI Research Center for Quantitative Renal 
Imaging and its funding programs please visit http://www.renalimaging.iupui.edu/ or contact the Center at 
renalimg@iupui.edu. 
Acknowledgments: The IUPUI Research Center for Quantitative Renal Imaging is supported by contributions 
from the IUPUI Signature Center Initiative, the Department of Radiology & Imaging Sciences; the Division of 
Nephrology, the IUPUI School of Science, the IUPUI School of Engineering & Technology, and the Indiana 
Clinical and Translational Sciences Institute (CTSI). 
 
“Indiana	Center	for	Biological	Microscopy”	
Kenneth	Dunn,	Malgorzata	Kamocka,	Seth	Winfree,	Bruce	Molitoris	
	
	
The	 Indiana	 Center	 for	 Biological	 Microscopy	 “ICBM”	 has	 been	 providing	 imaging	
capabilities	 to	 Indiana	University	Researchers	 since	1996.	 In	2002	 the	 ICBM	has	become	
the	NIDDK	George	O'Brien	Center	for	Advanced	Microscopic	Analysis,	whose	objective	is	to	
develop	methods	of	intravital	multiphoton	microscopy	for	renal	research.	For	the	last	few	
years	 the	 Center	 has	 been	 providing	 an	 intravital	 microscopy	 service	 for	 Cancer	 Center	
investigators	through	the	Optical	Microscopy	Core	for	the	CEMH.		
We	are	organized	around	the	principle	of	providing	researchers	with	access	to	and	training	
on	 the	 latest	 instruments	 in	 optical	 microscopy.	 We	 emphasize	 hands‐on	 access	 to	
instruments	for	individual	investigators	and	unparalleled	assistance	from	on‐staff	imaging	
experts.	In	addition	to	providing	efficient,	state‐of‐the‐art	biomedical	imaging	support,	the	
center	is	also	actively	involved	in	biological	imaging	research	and	the	development	of	new	
methods	of	microscopy	and	digital	image	analysis	software.		
The	ICBM	imaging	facility	is	located	in	Research	II	Building	(second	floor)	of	IUPUI	campus	
and	 is	 available	 to	 anyone	 at	 the	 Indiana	 University	 and	 researchers	 from	 outside	 the	
institution.	
 
The 3D Bioprinting Core at IUSM/IUPUI 
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Prenatal and post-natal development, wound healing, and other tissue generating 
activities in the body rely on processes whereby aggregates of cells generate tissues. 
During this process, cell aggregates rely on cues form cell-cell contact, other internal 
cues, and external cues to stimulate extracellular matrix secretion, cell migration (self-
organization) within the aggregate, and cellular differentiation, thereby resulting in a 
tissue. 
 
Ideally, engineering a tissue construct should be achieved in a similar process. While 
small cell aggregates called spheroids (1,000 to 100,000 cells each) have been studied, 
assembling spheroids into larger cell aggregates into a useful tissue construct was only 
achieved with the recent launch of the semi-automated ‘Regenova’ 3D-bioprinter. Using 
robotically-controlled placement, the Regenova assembles (prints) cell spheroids into a 
pre-designed 3D pattern onto a temporary support made from an array of microneedles. 
The spheroids remain on the needle support as the spheroids fuse to one another. 
Meanwhile, cells within the spheroids react to internal and external cues promoting 
extracellular matrix production, cell migration, and differentiation, forming a tissue 
construct 
 
Renal imaging related 3D bioprinting applications include generating healthy and 
damaged tissue models for imaging analysis, characterizing tissue response to imaging 
reagents, and developing tissue-based precision medicine models. 
 
Peer-reviewed publications demonstrate that this tissue engineering approach is viable 
for bioprinting vascular, tracheal, and urethral tubes, and other tissue constructs. The 
first Regenova for academic use in North America was installed on the IUSM/IUPUI 
campus and is the featured instrument in the newly formed 3D Bioprinting Core. Our 
Core facility is staffed with qualified personnel to support bioprinting projects. We have 
begun working with labs on projects addressing bone, cartilage, liver, pancreas, skin, 
vasculature, etc. This facility will initiate significant tissue engineering and biofabrication 
progress at IUSM/IUPUI, placing our institution and its medical school at the forefront of 
the biofabrication revolution.  
 
 
Image-based Computational Assessment for Severity of Renal Artery Stenosis 
Huidan (Whitney) Yua,b, Anurag Deba, Avinash Mumbaraddia, Alan P. Sawchukb, Raghunandan 
Motaganahallib, Michael C. Dalsingb 
aMechanical Engineering Department, Indiana University-Purdue University, Indianapolis 
(IUPUI), Indiana 46202, USA 
bDivision of Vascular Surgery, School of Medicine, Indiana University, Indiana, 46202, USA 
 
We develop a computational technique of modeling and analysis based on patient’s CT/MRI 
imaging information and Doppler Ultrasound test for non-invasive assessment of the severity of 
renal artery stenosis (RAS) through its contribution to the overall renal resistance. The attractive 
advantages of such a technique include the low cost of facility, personnel, and supplies; the fully 
human subject protection; the short and flexible time cycle, and the direct human subject results. 
Unified mesoscale lattice Boltzmann models, for anatomical extraction and fluid dynamics, and 
GPU (Graphics Processing Unit) parallel computing technology are seamlessly integrated in one 
computational platform thus neither data transformation and mesh generation nor remote 
supercomputing required to achieve fast computation within clinically accepted time for medical 
diagnose and assessment. We establish the relationship between the degree of stenosis (S), and 
the physical attributes related to the renal resistance through a parametric study by varying S. 
Our computational results include three aspects. First, pressure decreases across a stenosis. When 
S increases, the transstenotic pressure gradient increases and the flow rate decreases. Second, the 
contribution of a RAS to the total renal resistance is minor and changes slowly when S < 85% 
whereas it becomes significant and changes rapidly when S > 85%. Third, it is found that the 
renal resistive index (RRI) remains almost the same when S < 73%. It decrease rapidly when S > 
73%. Our computational study suggests that renal artery stenting would only benefit patients 
with large degree of stenosis, i.e. 85%, and that the current clinically utilized RRI may not be an 
appropriate indicator for renal resistance. However, more application applied studies and 
corresponding validation with invasive medical measurements medical validations are required 
before a definitive conclusion can be made. 
The Complex Hemodynamics in Aortorenal Vessel System 
	
AP	Sawchuka,	W.	Yua,b,	MC	Dalsinga	
aDivision of Vascular Surgery, School of Medicine, Indiana University, Indiana, 46202 
bMechanical Engineering Department, Indiana University-Purdue University, 
Indianapolis (IUPUI), Indiana 46202 
	
	
This study evaluates the interrelationship between the renal artery anatomy, intrinsic 
resistance and shear stress in order to understand the forces leading to renal artery 
atherosclerosis. Patient specific computational modeling of renal artery blood flow 
derived from CT arteriography was used to evaluate the relationship between renal artery 
anatomy, intrinsic renal arteriolar resistance, shear stress and plaque formation. The fluid 
dynamic techniques used have been validated with patient specific duplex ultrasound 
results and experimental studies done in our laboratory and others. The anatomy of the 
aorta and renal arteries had the greatest effect on vorticity and shear stress and our 
findings of eddy currents and areas of low shear on the cephalad wall of the renal artery 
correlated with a previous experimental finding of plaque development primarily 
occurring in this region. Beyond anatomical effects, small changes (25 percent) in distal 
intrinsic renovascular resistance consistent with increased arteriolar tone had a significant 
effect on further flow and pressure distortions and shear stress reductions. The presence 
of up to 40 percent renal artery stenosis at the orifice had little effect on these 
parameters.The anatomic relationship of the aorta and renal arteries as well as small 
changes (25 percent) in renal arteriolar tone have significant effects on renal artery blood 
flow patterns, pressures and shear stress which potentiate the development of 
atherosclerosis. Up to 40 percent renal artery stenosis at the orifice had little effect.  
These limited changes in intrinsic renovascular resistance are the one factor that is most 
treatable for the prevention of renal artery stenosis. This level of resistance may be below 
the level detectable by the renal resistance index. Improved methods for detecting small 
changes in renovascular resistance and medications or treatments specifically modifying 
end arteriole tone are needed to limit the morbidity and mortality of renovascular disease.  
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High Frequency Ultrasound of In Vivo Murine Renal Artery and Vein Blood Flow 
 
Frederick Damen1, Arvin Soepriatna1, Shelby Abrams1, Amy Bogucki1, Ron Korstanje2, Craig J. Goergen1 
1Purdue University, West Lafayette, IN; 2The Jackson Laboratory, Bar Harbor, ME 
 
The renal system serves a critical role in the modulation of plasma composition and 
volume, maintaining body fluids in homeostatic conditions. In order to further our 
understanding of how blood flow to the kidneys is affected by glomeruli density, we used 
high frequency ultrasound to measure renal blood flow of both C57BL/6J (B6) and FVB/J 
(FVB) mice in vivo. We hypothesized that B6 mice, previously shown to have a larger 
glomeruli count, will have higher arterial and venous blood flows. Two-dimensional B-
Mode, M-Mode, color Doppler, and pulsed wave Doppler were acquired using a 40MHz 
transducer on two separate occasions for both left and right renal arteries and veins (n=8 
B6, n=8 FVB). Mean arterial blood flow was higher in B6 mice when compared to FVB 
mice for both right (52.5±22.3 mm3/s vs. 26.6±13.2 mm3/s, p<0.05) and left (47.4±18.6 
mm3/s vs. 31.7±21.5 mm3/s, p<0.05) kidneys. Mean venous blood flow was also higher 
between B6 and FVB mice in both right (34.7±13.7 mm3/s vs. 18.6±8.8 mm3/s, p<0.05) 
and left (32.4±11.2 mm3/s vs. 15.0±10.7 mm3/s, p<0.05) kidneys.  Figure 1A shows the 
outline of a kidney overlaid onto a sample color Doppler image. Figure 1B shows an 
example of both arterial and venous pulsed wave Doppler analyses for that same kidney. 
In conjunction with our original hypothesis, B6 mice showed higher measured arterial and 
venous blood flows, potentially due in part to the higher number of glomeruli. Future work 
will focus on imaging other murine strains with varying glomeruli densities.		
	
Figure	1	
	
1
Combination of micro CT with infrared spectroscopy provides the most complete approach for stone analysis
James C. Williams, Jr.*, James E. Lingeman, Indianapolis, IN
INTRODUCTION AND OBJECTIVES: Analysis of composition of urinary stones is essential for proper diagnosis and management, but existing methods 
are known to be prone to error and are difficult to assess for accuracy using real stone specimens. Our group has been using micro CT for stone analysis now for 
15 years, and here we report our results for analyses with patient stone specimens.  
METHODS: All stones were macro-photographed and then scanned using a Skyscan 1172 Micro CT system, a non-destructive method. Following this, 
stones were analyzed using a Bruker Alpha-T Infrared Spectrometer (FT-IR), and results were compared. 
RESULTS: In 472 stone specimens, the majority minerals were calcium oxalate (CaOx, 60.0%), apatite (12.3%), struvite (8.5%), uric acid (8.1%), 
brushite (7.6%), and minor types (3.6%) that included cystine, urates, various phosphates, and pharmaceuticals. Micro CT by itself correctly identified all the major 
and minor minerals in 86.4% of the specimens. About half of the failures with micro CT were for rare components (e.g., whitlockite), but micro CT also missed 
brushite in 11 of the 36 specimens containing that mineral, as brushite can appear on micro CT with an x-ray attenuation value very close to that of CaOx. There 
were also 14 specimens in which micro CT either failed to detect or incorrectly specified struvite; this is because struvite often mixes with other minerals in a 
manner that makes it difficult to recognize. FT-IR was also found to be in error in 12.5% of the specimens because it missed minor components (typically apatite in 
low total percentage in the specimen) that were confidently identified using micro CT. Used together, the combination of micro CT with FT-IR provides what is 
arguably the most complete analysis of urinary stones that is presently available. Moreover, the combination allows identification of complex mineral combinations 
within stones, as the micro CT imaging can target specific regions of a specimen for FT-IR analysis (see figure). 
CONCLUSIONS: Accurate identification of stone mineral is a difficult challenge beyond the ability of a single methodology. The non-destructive nature of 
micro CT makes it a powerful complement to existing spectroscopic methods for analyzing stones. 
Source of Funding: NIH P01 DK56788, NIH S10 RR023710 
Magnetization Transfer MRI Noninvasively Detects Renal Fibrosis Swine Atherosclerotic Renal Artery Stenosis at 3.0 T 
Kai Jiang1, Christopher M. Ferguson1, John R. Woollard1, James D. Krier1, and Lilach O. Lerman1 
 
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA 
Introduction 
We have previously shown that magnetization transfer (MT)-MRI, which evaluates the presence of macromolecules, offers a noninvasive tool to probe renal fibrosis in 
murine renal artery stenosis (RAS) at 16.4 T. We hypothesized that MT-MRI can detect renal fibrosis in a swine model of atherosclerotic RAS (ARAS) at 3.0 T.  
Methods 
Phantom Study.  MRI studies were performed on a GE Signa HDxt 3.0 T scanner using an MT-prepared gradient echo sequence. The appropriate offset frequency was 
selected in a collagen phantom study. Images with (Mt) and without (Mo) MT preparation were acquired and MT ratio (MTR) calculated as: (M0-Mt)/ M0. The 
percentage change in MTR (%chMTR) compared to a reference frequency was also calculated. 
Animal Study. Ten weeks after RAS induction in 6 control and 7 ARAS pigs, cortical and 
medullary MTRs were measured and normalized by dorsal muscle MTR to correct for B1 
variation. The %chMTR from 1000 to 600 Hz was then calculated.  
Masson’s trichrome staining was subsequently performed on harvested kidney and the fraction 
of tissue fibrosis quantified. 
Results 
Phantom Study The 50% collagen phantom showed larger MTRs (Fig. 1a&b) but 
smaller %ch MTRs (Fig. 1c) than 25% collagen. To achieve high MT sensitivity with little free 
water saturation, offset frequencies at 600 and 1000 Hz were chosen for in-vivo studies. 
Animal Study. Greater MTR in ARAS vs. normal kidneys (Fig. 2a) was more evident at 1000 
than 600 Hz (Fig. 2b), whereas %chMTR was markedly lower in ARAS kidneys (Fig. 2c).  
ARAS kidneys showed more fibrosis than controls (Fig. 2d-e). Compared to MTR (Fig. 3a&b), 
%chMTR (Fig. 3c&d) showed a better correlation with ex-vivo fibrosis. 
Conclusion 
A change in renal MTR values between offset frequencies may be a novel and useful tool for 
detecting renal fibrosis in swine ARAS at 3.0 T MRI.  
 
 
 
  
 
Figure 1. Phantom study. a. Representative MTR maps at 600, 
800, and 1000 Hz. b. MTR with offset frequency from -1600 to 
1600 Hz. c. %chMTR at different offset frequencies (800 to 1600 
Hz) with the reference frequency at 600 Hz. 
Figure 3. Correlation between fibrosis by ex-vivo trichrome staining and 
in-vivo MTR at 1000 Hz (a&b) or %chMTR (c&d) in cortex (a&c) and 
medulla (b&d). 
Figure 2. In-vivo MT. a. Representative MTR maps of control and ARAS 
kidneys at 1000 and 600 Hz. b. Cortical and medullary MTR. c. Cortical 
and medullary %chMTR. d. Representative images of trichrome-stained 
cortical and medullary tissues from control and ARAS kidneys. e. Degree 
of fibrosis quantified from trichrome staining.  
Title 
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Synopsis (limit 100 words) 
In this study, we used multi-shell diffusion-weighted imaging in an animal model of Chronic Kidney 
Disease (CKD).  We focus on the functional changes in the kidney using diffusion tensor imaging (DTI) 
and q-space imaging (QSI).  Four Wistar rats received surgical procedure to induce ischemic fibrosis in 
their left kidney.  The multi-shell diffusion-weighted imaging was performed on the acute stage, day 2 
after the surgery.  In the acute stage, the renal medulla showed significant decrease in overall diffusivity 
measured by DTI and increase in tissue restriction measured by q-space imaging.  
Words: 89 
 
Limit 750 
Purpose: 
Chronic Kidney Disease (CKD) is characterized by progressive renal fibrosis that leads to end-stage renal 
failure and the need for dialysis or kidney transplantation1.  There is a compelling need for the 
development of biomarkers to monitor CKD progression and help guide the evaluation of experimental 
treatment strategies.  We hypothesize that characteristics of water diffusion and flow will serve as a 
biomarker for renal fibrotic burden.  The objective of this study is to develop and evaluate the utility of 
magnetic resonance imaging based diffusion tensor2 and non-parametric q-space imaging techniques3 as 
biomarkers of renal fibrosis in an animal model of CKD.   
Method: 
Preparation of the animal CKD model: An ischemia/reperfusion model was used to create hypoxia 
induced renal fibrosis in Wistar rats (N=4).  In each animal the renal artery in one kidney was clamped for 
50 minutes to induce ischemia and hypoxia (IHK), followed by restoration of blood flow.  The contralateral 
kidney served as a control reference (CON).  MRI imaging:  MRI was performed 2 days following 
surgery.  During each imaging session, rats were sedated and placed in a head-first prone position. All 
animal handling followed institutional Animal Care and Use Committee (IACUC) guidelines. The MRI 
diffusion pulse sequence was a single-shot spin-echo echo-planar imaging (SS-SE-EPI) sequence with 
multiple diffusion-weighting b-values (i.e. 3 shells with b-values of 150, 300 and 450 s/mm2) and multiple 
diffusion-weighting directions at each shell (i.e., 10, 19 and 30, respectively).  Diffusion directions in each 
shell and in the projected sphere with all directions (i.e., total 59) were optimized for uniform diffusion 
sampling in the spherical space4. The repetition time (TR) is 2200 ms and echo time (TE) is 73.6 ms. A 
total of four signal averages was performed. The imaging parameters were field-of-view (FOV) = 128 x 64 
mm, matrix size = 128 x 64, isotropic voxel size of 1 mm3, and 20 oblique coronal slices.  Image 
Processing: DTI derived parameters including axial diffusivity (AD), radial diffusivity (RD), mean 
diffusivity (MD), and fractional anisotropy (FA) were computed5. A non-parametric q-space approach was 
used to compute the probability density function (PDF), a marker of very slow water diffusion (P0)3. ROIs: 
In the b0 image, anatomically defined layers of kidney are clearly identified. Two distinct ROIs were 
placed on medulla and cortex (Figure 1). Statistics: Student’s paired two tailed t-test were performed on 
individual ROI’s and multiple comparison Bonferroni corrections were implemented, two-tail p value < 
0.01 was considered significant.  
 
 Results 
All DTI indices (AD, RD, MD, and FA) showed statistically significant reductions in the medulla of the IHK 
kidneys (Figure 2A and B).  The tissue restriction index, P0, increased in the medulla of the IHK kidneys 
(p < 0.01).  No significant changes in DTI parameters or tissue restriction index were observed in the 
renal cortex of the IHK kidneys (Figures 2C and D). 
 
Discussion and Conclusion 
The observed reduction in mean diffusivity measured with DTI and increased P0 (population of very slowly 
diffusing water molecules) in renal medulla are consistent with the formation of fibrotic regions within the 
tissue.  It is thought that DTI axial diffusivity is an indicator of intra-tubular flow in the renal medulla6-9  and 
radial diffusivity is an indicator of water reabsorption rate6.   The changes in AD and RD observed in this 
study suggest that intra-tubular flow and water reabsorption rate decreased in the IHK kidney.  The 
dramatic decrease in FA suggests the impact of intra-tubular flow is much higher that the impact of water 
reabsorption rate in our renal hypoxia induced fibrosis model.  In addition, the medulla appear more 
sensitive ischemia induced hypoxia than renal cortices.  
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Figure 1: b0 (with ROIs), DTI and P0 maps for CON and IHK kidney after two days 
of surgical intervention. The scale of AD, RD and MD are from 0 to 3, 1.5 and 3*10
-
3
mm
2
/s respectively. FA and Po are scaled from 0 to 0.4 and 0.3 to 0.8 respectively. 
Figure 2: DTI and q-space parameters 
for various ROIs are compared 
between CON (blue bars) and IHK 
(grey bars) kidney. The orange bars 
denotes standard deviations. The 
statistically significant parameters (p < 
0.01) are shown by connecting lines. 
The units for diffusivity are 1*10
-
3
mm
2
/s.. 
Development of a Novel Magnetic Resonance Imaging (MRI) Acquisition and Analysis 
Workflow for the Quantification of Renal Hemorrhagic Injury.    
Paul R. Territo1, Rajash K. Handa2*, Philip M. Blomgren2, Lin Chen1, Cynthia D. Johnson2, 
Lie Jiang1, Bret A. Connors2 and Gary D. Hutchins1. 
1Department of Radiology and 2Department of Anatomy and Cell Biology, Indiana 
University School of Medicine  
Introduction and Objective. Shock wave lithotripsy (SWL) has been used as an effective 
noninvasive treatment for nephrolithiasis; however, SWL can produce undesirable side 
effects in the target tissue resulting in renal hemorrhagic injury. The current gold standard 
for quantifying SWL-induced tissue damage is based on morphometric detection of renal 
hemorrhage in serial tissue sections from fixed kidneys. This methodology is time/labor 
intensive; requires expert knowledge of renal anatomy and image processing to generate 
accurate results and is tissue destructive. We sought to develop a non-destructive method 
that would permit rapid assessment of whole kidney hemorrhagic lesions in post-mortem 
organs using native tissue contrast that would reduce cycle time while maintaining 
information content of lesion volumes. 
Methods. Kidneys of anesthetized adult farm pigs were targeted with shock waves (SWs) 
using the Compact S lithotripter (2500 SWs at various power levels and SW rates). Kidneys 
were then perfusion fixed in situ, harvested and prepared for tissue injury quantification. T1 
weighted (T1W) 3D-FLASH and T2 weighted (T2W) 3D-SPACE images were acquired on a 
Siemens 3T Tim Trio using a high sensitivity 72mm inner diameter 8 channel volume coil. 
Images were co-registered, normalized, difference images generated, and volumes 
classified and segmented using a Multispectral Neural Network classifier. Kidneys were 
then subjected to standard morphometric analysis for measurement of lesion volumes.  
Results. Classifications of T1W, T2W and difference image volumes were correlated with 
morphometric measurements of whole organ lesion volumes. The data can be described by 
the relationship y = 0.49x + 0.03 (R2 = 0.99, N = 9), where the lesions ranged broadly for 
morphology (x = 0 - 2.5%) and MRI (y = 0 - 1.3%). 
Conclusions. These preliminary data suggest that the MRI technique may provide a rapid, 
low cost and reliable means to evaluate renal injury lesion volumes due to SWL and other 
endourological treatment modalities; and when adapted for in vivo use may provide 
clinically useful information on the lesion severity, extent, and distribution.               
 
Volumetric Comparison of Automatically Segmented Hippocampal Subfields from 4‐Min Accelerated versus 8‐Min T2‐weighted 3T MRI Scans
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1. BACKGROUND
A high resolution (0.4mm in plane) T2‐weighted turbo spin‐echo sequence has been studied 
to enable hippocampal subfield volumetry [1,2]. The standard 8 minute protocol is 
vulnerable to motion in clinical populations. Acceleration by factor 2 saves scan time and 
reduces susceptibility to motion but at a cost to signal‐to‐noise ratio. We compared 
hippocampal subfield volumes using standard and accelerated protocols.
2. MATERIALS & METHODS
groups. Pairwise group analyses were performed, covaried for age,
gender and total intracranial volume, to determine whether similar group differences could 
be observed using 4‐minute versus 8‐minute data.
4. CONCLUSIONS
The 4‐minute and 8‐minute protocols, coupled with ASHS segmentation, yield similar 
volumetric estimates for hippocampal subfields and differences between groups. The 
accelerated protocol can provide reliable imaging data for investigation of hippocampal 
subfield volumetry in SCD/MCI/AD‐related MRI studies and may be less vulnerable to 
motion.
1. Human Brain Mapping (2015) 36:258‐287.
2. Neuroimage (2010) 53:1208‐1224.
3. RESULTS
Acknowledgements: Supported in part by NIH R01 LM011360, K99 LM011384, U01 AG024904, RC2 
AG036535, R01 AG19771, P30 AG10133, and NSF IIS‐1117335 at IU. Data used in preparation of this 
article  were obtained from the ADNI database, which was funded by NIH U01 AG024904.
The sample included 12 cognitively normal control (CN), 9 
subjective cognitive decline (SCD), 12 mild cognitive impairment 
(MCI), and 7 Alzheimer’s disease (AD) participants recruited from 
an ongoing study at the Indiana Alzheimer Disease Center (IADC). 
The standard 8‐minute ADNI protocol and a 4‐minute accelerated 
protocol with GRAPPA (activating generalized autocalibrating
partially parallel acquisitions) acceleration factor of 2 were run on 
a Siemens Prisma 3T MRI. ASHS [1] was used to segment 10 
primary labels (Table 1). Intraclass correlation coefficients (ICCs) 
were computed using SPSS 23 to perform reliability tests 
between 4‐minute and 8‐minute scans within and across the 4
Table 2 shows the results of the ICC analyses 
within each group and across all the groups. 
Table 3 shows the results for group 
analyses, including CN vs SCD, CN vs 
MCI, and CN vs AD.
Figure 2 shows 
two examples of 
effect size plots. 
The regional 
differences 
detected by the 
4‐minute data 
and 8‐minute 
data were very 
similar.
Figure 1 shows an example plot of the ICC analysis across all 
groups. Significant agreement was observed on most measures. 
While CA2 and CA3 showed lower ICCs, the combined measure 
CA2‐3 demonstrated higher reliability. 
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ABSTRACT 
The liver performs a number of critical physiological functions such as processing nutrients and 
removing toxins from the blood including metabolizing and excreting drugs. For this reason, a major 
effort in pharmacology is focused on drug liver transport. The goal of this effort is to reduce drug-
induced liver injury which is the single biggest source of failure in the development of new drugs and 
the primary reason for withdrawal of approved drugs from the market. The fundamental process of 
liver transport is one in which compounds present in the blood are transported into and processed by 
liver cells.  
Here we propose methods to infer the dynamics of transport of fluorescent dyes -- which serve as 
proxies for drugs -- from data collected in live animals. The proposed study consists of two specific 
aims: (1) since we expect the fluorescence properties of probes to depend on their location in the living 
system, we want to determine the relationship between in vivo measured fluorescence and probe 
concentration, (2) develop a model of molecular transport that would allow us to estimate kinetic 
parameters not directly measurable. 
We have preliminarily proposed a model for liver transport that is defined by a system of non-linear 
ordinary differential equations.   
Our results show that we can develop a novel experimental platform that will extend and 
fundamentally improve the predictive value of preclinical drug safety studies. 
Physics of Drug Transport   
The Growth and Impact of ADNI Genetics Publications as Measured by Science Mapping 
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Background: 
The Genetics Core of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) provides genetic 
resources and facilitate research opportunities in qualitative and quantitative genetics using 
ADNI multidimensional phenotypes. Genotyping and sequencing data have been generated for 
ADNI-1/GO/2 participants, and are available to the scientific community. Here we visualize and 
evaluate the scientific growth and impact of ADNI genetics studies published from 2008 through 
2015. 
Methods: 
A Scopus publication search, using keywords related to both ADNI and genetics, was performed 
to identify papers published between 2008-2015. Manual filtering was used to identify 
publications where ADNI genetics data were analyzed. Google Refine was applied to unify 
author names within one institution and keywords. Science of Science Tool (Sci2) [1] was 
employed to perform a comprehensive evaluation and visualization of institution-level 
collaborations among ADNI genetics studies, and interactions among ADNI genetics research 
topics. 
Results: 
The Scopus search followed by manual filtering yielded a total number of 376 ADNI genetics 
publications. Co-publication networks over this period with statistical evaluation are shown in 
Figures 1-2. The numbers of institutions and collaborations increased over the years, as did the 
number of publications. Collaborations jumped in 2014-2015, thanks to both the increased 
number of publications and several publications with 50+ institutions (e.g., [2]). Figure 3 shows 
keyword co-occurrence networks at multiple scales: 3,034 links are identified among 428 
keywords. Keywords with degree ≥ 5 are labeled and grouped into four categories including 
genotype, phenotype, analysis and others, where high connections exist among both intra- and 
inter-category keywords.  
Conclusions: 
Science mapping can reveal the growth and impact of ADNI genetics publications. We observe 
an increasing number of publications and collaborations, as well as densely interconnected 
research topics and categories (genotype, phenotype, analysis and others). With the recent 
release of ADNI multi-omics data (e.g., whole genome sequencing, transcriptomics, and 
metabolomics), coupled with many other existing and new ADNI resources, we expect to see 
further growth of ADNI genetics research.  
[1] Sci2 Tool. https://sci2.cns.iu.edu. 
[2] JAMA Neurology, 71(11): p.1394-1404, 2014. 
